全文获取类型
收费全文 | 561篇 |
免费 | 46篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 36篇 |
妇产科学 | 16篇 |
基础医学 | 117篇 |
口腔科学 | 1篇 |
临床医学 | 58篇 |
内科学 | 114篇 |
皮肤病学 | 16篇 |
神经病学 | 68篇 |
特种医学 | 8篇 |
外科学 | 47篇 |
预防医学 | 19篇 |
眼科学 | 12篇 |
药学 | 41篇 |
肿瘤学 | 50篇 |
出版年
2024年 | 2篇 |
2023年 | 10篇 |
2022年 | 22篇 |
2021年 | 42篇 |
2020年 | 24篇 |
2019年 | 35篇 |
2018年 | 38篇 |
2017年 | 25篇 |
2016年 | 24篇 |
2015年 | 27篇 |
2014年 | 21篇 |
2013年 | 36篇 |
2012年 | 74篇 |
2011年 | 48篇 |
2010年 | 19篇 |
2009年 | 20篇 |
2008年 | 31篇 |
2007年 | 23篇 |
2006年 | 21篇 |
2005年 | 21篇 |
2004年 | 14篇 |
2003年 | 13篇 |
2002年 | 11篇 |
2001年 | 2篇 |
1999年 | 1篇 |
1998年 | 1篇 |
1993年 | 1篇 |
1991年 | 2篇 |
1989年 | 1篇 |
排序方式: 共有609条查询结果,搜索用时 15 毫秒
91.
92.
93.
Ana A. Baumann Vincent Mutabazi Angela L. Brown Cole Hooley Dominic Reeds Cecile Ingabire Vedaste Ndahindwa Aurore Nishimwe W. Todd Cade Lisa de las Fuentes Enola K. Proctor Stephen Karengera Kenneth B. Schecthman Charles W. Goss Kevin Yarasheski Brad Newsome Eugene Mutimura Victor G. Davila-Roman 《Global Heart》2019,14(2):135-141
BackgroundCardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide and in low- and middle-income countries, and hypertension (HTN) is a major risk factor for CVD. Although effective evidence-based interventions for control of HTN in high-income countries exist, implementation of these in low- and middle-income countries has been challenging due to limited capacity and infrastructure for late-phase translational research. In Rwanda, the 2015 STEPS NCD (STEPwise Approach to Surveillance of Noncommunicable Diseases) risk survey reported an overall prevalence of HTN of 15% (95% confidence interval [CI]: 13.8 to 16.3) for those ages 15 to 64 years; prevalence increased with increasing age to 39% (95% CI: 35.7 to 43.1) for those ages 55 to 64 years; CVD was the third most common cause of mortality (7%). Suboptimal infrastructure and capacity in Rwanda hinders research and community knowledge for HTN control.ObjectivesTo address the issue of suboptimal capacity to implement evidence-based interventions in HTN, this project was designed with the following objectives: 1) to develop a regional needs assessment of infrastructure for dissemination and implementation (D & I) strategies for HTN-CVD control; 2) to develop HTN-CVD research capacity through creation of countrywide resources such as core research facilities and training in the fields of HTN-CVD, D & I, and biostatistics; and 3) to engage and train multiple stakeholders in D & I and HTN-CVD evidence-based interventions.MethodsA weeklong training program in HTN-CVD, biostatistics, and D & I was conducted in Rwanda in August 2018, and pre- and post-D & I training competency questionnaires were administered.ResultsQuestionnaire results show a statistically significant increase in D & I knowledge and skills as a result of training (full scale pre- to post-test scores: 2.12 ± 0.78 vs. 3.94 ± 0.42; p < 0.0001).ConclusionsUsing principles of community engagement and train-the-trainer methods, we will continue to adapt guidelines and treatments for HTN-CVD developed in high-income countries to the context of Rwanda with the goal of establishing a sustainable platform to address the burden of disease from HTN-CVD. 相似文献
94.
95.
Successful renal retransplantation after graft loss from BK polyomavirus infection in a human immunodeficiency virus‐positive patient
下载免费PDF全文
![点击此处可从《Transplant infectious disease》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Aurore Barthélemy Nicolas Bouvier Renaud Verdon Valérie Chatelet Bruno Hurault de Ligny 《Transplant infectious disease》2016,18(6):946-949
We report the case of a human immunodeficiency virus‐seropositive patient whose initial kidney transplant failed because of BK polyomavirus‐induced nephropathy, and who underwent a second transplantation 3 years later. BK viruria was detected 1 day after transplantation. After 1 month, BK viremia developed along with a donor‐specific antibody. After decreasing tacrolimus and mycophenolic acid and 2 courses of intravenous immunoglobulins, BK viremia and donor‐specific antibody permanently disappeared, with stable renal function. 相似文献
96.
Varying proliferative and clonogenic potential in NRAS‐mutated congenital melanocytic nevi according to size
下载免费PDF全文
![点击此处可从《Experimental dermatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Sarah Guégan Natacha Kadlub Arnaud Picard Thomas Rouillé Christelle Charbel Aurore Coulomb‐L'Hermine Alexandre How‐Kit Sylvie Fraitag Selim Aractingi Romain H. Fontaine 《Experimental dermatology》2016,25(10):789-796
Congenital melanocytic nevi (CMN) are benign proliferations that may be associated with various consequences depending on their size. They are characterized by a specific molecular signature, namely a postzygotic somatic NRAS or BRAF mutation. We have recently reported that large CMN (lCMN), which are classically associated with an increased melanoma risk, harbour cell subpopulations with specific clonogenic and tumorigenic potential. We wished to ascertain whether cells displaying similar properties persisted postnatally in medium CMN (mCMN). Eighteen medium M1, nine large and one giant NRAS‐mutated CMN were prospectively included in the study. Subpopulations of mCMN cells expressed stem cell/progenitor lineage markers such as Sox10, nestin and Oct4, as was the case in lCMN. Nevertheless, conversely to lCMN, mCMN cells with clonogenic properties were rarer. In vitro, approximatively one in 1500 cells isolated from fresh mCMN formed colonies that could be passaged. In vivo, mCMN seemed to harbour cells with less proliferative potential than the larger lesions as lCMN biopsies displayed a threefold expansion compared to mCMN when xenografted in Rag2?/? mice. Thus, our data revealed variations in clonogenicity and tumorigenic properties in NRAS‐mutated CMN according to size. 相似文献
97.
98.
99.
de Lavareille A Roufosse F Schmid-Grendelmeier P Roumier AS Schandené L Cogan E Simon HU Goldman M 《The Journal of allergy and clinical immunology》2002,110(3):476-479
The idiopathic hypereosinophilic syndrome is associated with expansion of an IL-5-producing T-cell subset in a subgroup of patients. Identification of such patients is critical to adequate management because there is some evidence that they present an increased risk for development of T-cell lymphoma. Although the T(H)2-like cells often bear an aberrant surface phenotype and can readily be detected with flow cytometry, we now show that lymphocyte phenotyping might be normal in some cases. In contrast, serum thymus and activation-regulated chemokine levels are consistently increased in such patients compared with others with persistent idiopathic hyper-eosinophilia and could therefore represent a useful diagnostic tool. 相似文献
100.